On the other hand, the Ras signaling molecule has been shown to be mutated/activated in cancer, including NSCLC, leading to the subsequent activation of Erk1/2 and resulting in cell proliferation and resistance to chemotherapy and radiation [71]. This evidence concerns the gene MAPK3 and cancer.